TELLME-40 CT Tablets

TELLME-40 CT is a fixed-dose antihypertensive combination containing Telmisartan 40 mg + Chlorthalidone 12.5 mg per tablet.

Telmisartan works as an angiotensin II receptor blocker (ARB). It blocks the action of angiotensin II, a hormone involved in blood-vessel constriction and blood-pressure regulation. Chlorthalidone is a thiazide-like diuretic that promotes the excretion of sodium and water, contributing to blood-pressure reduction.

The combination is intended for blood-pressure management in patients requiring antihypertensive therapy, under appropriate medical supervision.

Uses / Indication

Primary use

TELLME-40 CT is used for the management of hypertension (high blood pressure).

Telmisartan is indicated for hypertension, while chlorthalidone is also indicated for lowering blood pressure.

Suitable website wording

TELLME-40 CT may be prescribed for:

• Management of hypertension
• Blood-pressure control when combination antihypertensive therapy is required
• Patients requiring the complementary antihypertensive effects of an ARB and diuretic

Key Features

• Dual-action antihypertensive combination
• Contains Telmisartan 40 mg
• Contains Chlorthalidone 12.5 mg
• ARB + thiazide-like diuretic combination
• Oral tablet formulation
• 10 × 10 Alu-Alu pack
• 100 tablets per pack
• Cardioz division product